These guidelines presume that four premises are accepted.
That research involving children is important for the benefit of all children and should be supported and encouraged, and conducted in an ethical manner.
That research should never be done on children if the same investigation could be done on adults.
That research which involves a child and is of no benefit to that child (non-therapeutic research), is not necessarily either unethical or illegal. ' That the degree of benefit resulting from a research should be assessed in relation to Examples. In cystic fibrosis, a research might be considered reasonable which involved an affected child having a sweat test that needed twice as much sweat as required for purely diagnostic purposes. The added discomfort to the child might be assessed as Negligible. If in addition a venepuncture was required, this might be judged to put the risk of discomfort and pain into the Minimal Risk category. But the potential benefit to other child sufferers from this common and serious disease might be deemed such as to make the Risk/Benefit ratio acceptable.
During the course of an operation for hernia, a fragment of skin from the incision might be required for a research involving tissue culture. The Risk could be judged Negligible, so that even if the research was not expected to have any direct clinical benefit but only to add to basic biological knowledge, it might be acceptable.
During the course of an abdominal operation, a renal biopsy might be taken for research purposes. The Risk here would be judged More than Minimal and the Benefit would have to be very large to justify it. But suppose the research aimed to resolve the problem of rejection of transplanted kidneys, with resulting lifesaving consequences both for children and adults with renal failure, this might be considered a Benefit of sufficient magnitude to justify the risk. 3. The procedure is quite apart from the necessary care or treatment of the child. For example, blood sampling; passage of oesophageal tube for pressure recording; application of face mask for respiration studies; placement of infant in plethysmograph chamber for thermal or respiratory studies; needle biopsy of skin or fat; or x-ray or isotope studies (see below). In general, ethical principles in therapeutic research involving children do not usually differ from those applying to adults, except that the age of the subject will often mean that parental understanding and agreement will be required.
In A controlled trial of hyposensitising injections of allergens in asthmatic children differs from the foregoing example in that some children (the controls) receive injections of inactive material. This might at first sight seem ethically questionable. However, the following consideration may lead to such a trial being judged acceptable. Until the result of the trial is known the children in either the treatment or the control group have a chance of gaining an advantage. The active therapy may prove superior and those in the treatment group gain an advantage. If, however, there are unpleasant or harmful side effects from the active therapy, the control group will have gained some advantage by not being exposed to those side effects. X-rays and isotopes An authoritative pronouncement on the ethical propriety of irradiating children (i.e. the use of x-rays or isotopes) for research purposes has recently been given by the International Commission on Radiological Protection.3 It states that 'the irradiation, for the purposes of such studies (i.e. of no direct benefit to the subject) of children and other persons regarded as being incapable of giving their true consent should only be undertaken if the expected radiation is low (e.g. of the order of one10th of the dose-equivalent limits applicable to individual members of the public) and if valid approval has been given by those 
